APA (7th ed.) Citation

Vonica, R. C., Butuca, A., Morgovan, C., Pumnea, M., Cipaian, R. C., Frum, A., . . . Gligor, F. G. (2025). Bevacizumab—Insights from EudraVigilance Database on the Assessments of the Safety Profile of Monoclonal Antibodies Used as Targeted Cancer Treatment. Pharmaceuticals (14248247), 18(4), 501. https://doi.org/10.3390/ph18040501

Chicago Style (17th ed.) Citation

Vonica, Razvan Constantin, et al. "Bevacizumab—Insights from EudraVigilance Database on the Assessments of the Safety Profile of Monoclonal Antibodies Used as Targeted Cancer Treatment." Pharmaceuticals (14248247) 18, no. 4 (2025): 501. https://doi.org/10.3390/ph18040501.

MLA (9th ed.) Citation

Vonica, Razvan Constantin, et al. "Bevacizumab—Insights from EudraVigilance Database on the Assessments of the Safety Profile of Monoclonal Antibodies Used as Targeted Cancer Treatment." Pharmaceuticals (14248247), vol. 18, no. 4, 2025, p. 501, https://doi.org/10.3390/ph18040501.